X-Received: by 2002:a05:622a:11cf:b0:31d:3d5e:6309 with SMTP id n15-20020a05622a11cf00b0031d3d5e6309mr8576163qtk.625.1656877796514;
Sun, 03 Jul 2022 12:49:56 -0700 (PDT)
X-Received: by 2002:a9d:7e91:0:b0:616:b9c7:48d2 with SMTP id
m17-20020a9d7e91000000b00616b9c748d2mr10727503otp.104.1656877796239; Sun, 03
Jul 2022 12:49:56 -0700 (PDT)
Path: i2pn2.org!i2pn.org!weretis.net!feeder6.news.weretis.net!news.misty.com!border2.nntp.dca1.giganews.com!nntp.giganews.com!news-out.google.com!nntp.google.com!postnews.google.com!google-groups.googlegroups.com!not-for-mail
Newsgroups: comp.text.pdf
Date: Sun, 3 Jul 2022 12:49:56 -0700 (PDT)
Injection-Info: google-groups.googlegroups.com; posting-host=155.94.216.100; posting-account=uMUGLQoAAAAoOKgG8uaQ7UiwufdxK7QN
NNTP-Posting-Host: 155.94.216.100
User-Agent: G2/1.0
MIME-Version: 1.0
Message-ID: <a4ecd001-e10e-4d57-ba99-7f3d48a1cf65n@googlegroups.com>
Subject: (PDF) Innovative Dosage Forms - Design and Development by Yogeshwar Bachhav
From: hesterholt14@gmail.com (hester holt)
Injection-Date: Sun, 03 Jul 2022 19:49:56 +0000
Content-Type: text/plain; charset="UTF-8"
Lines: 1